The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and Hypoxia-inducible factor 1-alpha

Mohammad Reza Sadeghi(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Hadiseh Kheiry(Tabriz University of Medical Sciences), Vahid Karpisheh(Tabriz University of Medical Sciences), Atefeh Khodakarami(Tabriz University of Medical Sciences), Mortaza Raeisi(Tabriz University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Fariba Karoon Kiani(Tabriz University of Medical Sciences), Asma Moslehi(Tabriz University of Medical Sciences), Ali Akbari(Harvard University), Badrossadat Rahnama(Tabriz University of Medical Sciences), Ali Masjedi(Tabriz University of Medical Sciences)
Research Square
January 31, 2024
10.21203/rs.3.rs-3902361/v1
Cited by 0

Related Papers

Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Large-scale migration into Britain during the Middle to Late Bronze Age
|Nature|2021|246
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202